#United States #Caris Life Sciences #Irving #Precision Medicine #AI TechBio

Caris Life Sciences: Pioneering Precision Medicine with Upcoming Conferences

Introduction
Caris Life Sciences® (NASDAQ: CAI) is set to showcase its groundbreaking innovations in precision medicine at two major healthcare conferences. Scheduled for mid-2026, these events will serve as platforms to discuss the future of healthcare technologies and their implications for patient care.

Conference Details
Caris will participate in the BofA Securities 2026 Health Care Conference from May 12-14, 2026, in Las Vegas, Nevada, presenting on May 12 from 10:00 AM to 10:30 AM PT. Following that, the company will feature at the Goldman Sachs 47th Annual Global Healthcare Conference taking place from June 8-10, 2026, in Miami, Florida, with their presentation scheduled for June 8 from 10:40 AM to 11:15 AM ET.

Both sessions will be accessible via live and recorded webcasts on Caris’ Investor Relations website, ensuring that stakeholders and the public can engage with their insights.

About Caris Life Sciences
Caris Life Sciences is recognized as a leader in the realm of patient-centric, next-generation AI TechBio innovations and precision medicine. The company has developed a comprehensive molecular profiling system that includes Whole Genome, Whole Exome, and Whole Transcriptome Sequencing. Through these advancements, they aim to unravel the complexities of diseases and propel patient outcomes.

Leveraging a combination of advanced artificial intelligence (AI) and machine learning technologies, Caris has established a robust clinico-genomic database crucial for analyzing disease molecular complexities. Their focus on high-performance computing enables the development of cutting-edge precision medicine diagnostic solutions. These solutions cater to various stages of patient diagnosis, from early detection and monitoring to therapy selection and drug development.

Founded with a clear vision of harnessing precision medicine to enhance the human condition, Caris is headquartered in Irving, Texas, with additional offices located in Phoenix, New York, Cambridge (Massachusetts), Tokyo, Japan, and Basel, Switzerland. Their services reach patients across the U.S. and into international markets through partnerships and distributor arrangements.

Significance of the Conferences
Attendance at these conferences underscores the importance of collaboration within the healthcare industry. By sharing their innovations, Caris Life Sciences emphasizes the crucial role of AI in transforming traditional medicine into a more predictive and personalized approach. This transition marks a pivotal moment in the way patient care is delivered, aiming for heightened efficacy and tailored therapeutic strategies.

Looking Ahead
As the healthcare landscape evolves, Caris Life Sciences is committed to prioritizing patient needs through technology and innovation. Their participation in these significant events highlights the company's dedication to advancing the field of precision medicine, helping to address some of the most pressing challenges faced in modern healthcare.

For live updates and detailed insights, interested parties are encouraged to follow the events through Caris' Investor Relations web pages. Stay tuned as Caris continues to drive advancements in healthcare and sets a benchmark for future innovations.

Conclusion
Caris Life Sciences stands at the forefront of a healthcare revolution, armed with unparalleled technology and a firm commitment to patients. As they prepare for these conferences, the anticipation surrounding their presentations reflects the growing interest and significance of precision medicine in today's society. With a focus on precision, innovation, and patient care, Caris is indeed shaping the future of healthcare.